Spruce Biosciences announces acceptance of abstract for ENDO presentation

Sruce Biosciences “announced that a submitted abstract was accepted for the 105th Annual Meeting of the Endocrine Society, or ENDO 2023, taking place June 15-18, 2023, in Chicago. In a poster presentation, the company will highlight the effect of tildacerfont on gonadotropins and testicular steroidogenesis in men with classic congenital adrenal hyperplasia, or CAH.”